Royal Brompton & Harefield NHS Foundation Trust
Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Other: 4 metre gait speed
- First Posted Date
- 2015-08-21
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 120
- Registration Number
- NCT02530736
- Locations
- 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
Prevalence of Pompe's Disease in Respiratory Clinics
- Conditions
- Pompe's Disease
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 400
- Registration Number
- NCT02527239
Electronic Hand Hygiene Monitoring and ICU Infection Rates
- Conditions
- Cross Infection
- Interventions
- Other: Weekly poster of unit performanceOther: Daily email of personal feedbackOther: Active reminder from badge
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 1065
- Registration Number
- NCT02511925
- Locations
- 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Other: 4MGS
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2015-10-27
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 46
- Registration Number
- NCT02445157
- Locations
- 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
Intrinsic PEEP and Laryngeal Aperture in COPD
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Procedure: Oesophageal balloon to measure intra-thoracic pressureProcedure: Fibre-optic laryngoscopyOther: standard lung function testsProcedure: face mask CPAPProcedure: variation of mouth pressure with CPAPOther: facemask pneumotachograph
- First Posted Date
- 2015-05-07
- Last Posted Date
- 2017-06-07
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 30
- Registration Number
- NCT02437630
- Locations
- 🇬🇧
michael apps MD, London, United Kingdom
The Predictive Ability of 4MGS in IPF
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Other: 4MGS
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 132
- Registration Number
- NCT02436278
- Locations
- 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom
A Pilot Study of Transcoronary Myocardial Cooling
- Conditions
- Acute Myocardial Infarction
- Interventions
- Other: Cohort A - Room temperature coronary perfusateOther: Cohort B - Cooled coronary perfusate
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT02312336
- Locations
- 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Uxbridge, Middlesex, United Kingdom
Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 70
- Registration Number
- NCT02286063
- Locations
- 🇬🇧
Royal Brompton Hospital, London, United Kingdom
A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics
- Conditions
- Asthma
- First Posted Date
- 2014-10-21
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 5
- Registration Number
- NCT02270827
- Locations
- 🇬🇧
Royal Brompton Hospital, London, United Kingdom
Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
- Conditions
- Venous ThrombosisInsulin Resistance
- Interventions
- Drug: Femoston ContiDrug: EVOREL® CONTI
- First Posted Date
- 2014-10-15
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT02264743
- Locations
- 🇬🇧
Chelsea and Westminster NHS Foundation Trust, London, United Kingdom
🇬🇧Royal Brompton and Harefield NHS Trust, London, United Kingdom
🇬🇧Imperial College Healthcare NHS Trust, London, United Kingdom